Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the Oesophagus (PANORAMIC)

This study has been terminated.
(low recruitment numbers)
Information provided by (Responsible Party):
Radboud University Identifier:
First received: December 15, 2010
Last updated: May 10, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: October 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)